The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients

por Blechschmidt, K, Sassen, S, Schmalfeldt, B, Schuster, T, Höfler, H, Becker, K-F
Publicado 2008

CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients

por Windmüller, C, Zech, D, Avril, S, Boxberg, M, Dawidek, T, Schmalfeldt, B, Schmitt, M, Kiechle, M, Bronger, H
Publicado 2017

Pelvic lymphadenectomy in vulvar cancer and its impact on prognosis and outcome

por Jaeger, A., Prieske, K., Mathey, S., Fischer, I., Vettorazzi, E., Kuerti, S., Reuter, S., Dieckmann, J., Schmalfeldt, B., Woelber, L.
Publicado 2021

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

por Kuhn, W, Schmalfeldt, B, Reuning, U, Pache, L, Berger, U, Ulm, K, Harbeck, N, Späthe, K, Dettmar, P, Höfler, H, Jänicke, F, Schmitt, M, Graeff, H
Publicado 1999

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

por Wimberger, P., Gilet, H., Gonschior, A-K., Heiss, M. M., Moehler, M., Oskay-Oezcelik, G., Al-Batran, S-E., Schmalfeldt, B., Schmittel, A., Schulze, E., Parsons, S. L.
Publicado 2012

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study

por Trillsch, F, Mahner, S, Vettorazzi, E, Woelber, L, Reuss, A, Baumann, K, Keyver-Paik, M-D, Canzler, U, Wollschlaeger, K, Forner, D, Pfisterer, J, Schroeder, W, Muenstedt, K, Richter, B, Fotopoulou, C, Schmalfeldt, B, Burges, A, Ewald-Riegler, N, de Gregorio, N, Hilpert, F, Fehm, T, Meier, W, Hillemanns, P, Hanker, L, Hasenburg, A, Strauss, H-G, Hellriegel, M, Wimberger, P, Kommoss, S, Kommoss, F, Hauptmann, S, du Bois, A
Publicado 2015